Cytosorbents (CTSO) Profit After Tax (2010 - 2026)
Cytosorbents' (CTSO) quarterly Profit After Tax came in at -$5.1 million in Q1 2026, down 246.79% YoY from $3.5 million in Q1 2025, and up 6.69% on a QoQ basis from -$5.5 million in Q4 2025.
Cytosorbents (CTSO) Profit After Tax (2010 - 2026) Analysis & Trends
Cytosorbents (CTSO) has 17 years of Profit After Tax data on file, last reported at -$5.1 million in Q1 2026.
- Quarterly Profit After Tax fell 246.79% year-over-year to -$5.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$11.8 million (up 26.44% YoY) and the FY2025 annual result came in at -$8.2 million, up 60.43% from the prior year.
- Profit After Tax rose to -$5.1 million in Q1 2026, from -$5.5 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $1.9 million in Q2 2025 to a low of -$12.2 million in Q3 2022.
- A 5-year average of -$5.7 million and a median of -$6.1 million in 2024 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2023 — Profit After Tax plunged 700.76% — and 2025, when it jumped 145.34%.
- Tracing CTSO's Profit After Tax over 5 years: stood at -$766126.0 in 2022, then slumped by 700.76% to -$6.1 million in 2023, then slipped by 23.34% to -$7.6 million in 2024, then advanced by 27.36% to -$5.5 million in 2025, then advanced by 6.69% to -$5.1 million in 2026.
- The last three Profit After Tax figures came in at -$5.1 million (Q1 2026), -$5.5 million (Q4 2025), and -$3.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 241.90 Mn |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 573.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 619.54 Mn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Cytosorbents | 21.98 Mn | 17.56 Mn | 7.05 Mn | -4.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.42 Mn |
| Mar 31, 2026 | -5.13 Mn |
| Dec 31, 2025 | -5.50 Mn |
| Sep 30, 2025 | -3.17 Mn |
| Jun 30, 2025 | 1.95 Mn |
| Mar 31, 2025 | -1.48 Mn |
| Dec 31, 2024 | -7.57 Mn |
| Sep 30, 2024 | -2.77 Mn |
| Jun 30, 2024 | -4.29 Mn |
| Mar 31, 2024 | -6.09 Mn |
| Dec 31, 2023 | -6.13 Mn |
| Sep 30, 2023 | -9.19 Mn |
| Jun 30, 2023 | -6.60 Mn |
| Mar 31, 2023 | -7.32 Mn |
| Dec 31, 2022 | -766,126.00 |
| Sep 30, 2022 | -12.20 Mn |
| Jun 30, 2022 | -10.88 Mn |
| Mar 31, 2022 | -8.97 Mn |
| Dec 31, 2021 | -9.31 Mn |
| Sep 30, 2021 | -6.41 Mn |